Monthly Archives: January 2017

SNMMI Develops USP Recommendations for Compounded Sterile Radiopharmaceuticals

SNMMI has developed USP recommendations for compounded sterile radiopharmaceuticals. The recommendations aim to address certain common practices in the field of nuclear pharmacy that are not adequately defined by generally accepted practice standards. The society believes there is confusion in … Continue reading

Posted in PET Drugs | Leave a comment

FDA Issues Draft Guidances on Compounding and Repackaging Radiopharmaceuticals

On December 28th, the FDA issued two draft guidances that describe FDA’s proposed policies regarding the compounding and repackaging of radiopharmaceuticals for human use by state-licensed nuclear pharmacies or federal facilities, and outsourcing facilities. According to FDA, “the policies proposed … Continue reading

Posted in PET Drugs | Leave a comment